Biotechnology
The biotech market
has finally roared back - punctuated by frequent bursts of heartstopping
volatility. Amidst this, pressing senior management challenges remains.
Startups need to keep burn rates under control. Newly
public companies need post-IPO strategies. Established players
need to prioritize development and devise creative ways to finance
it without rocking the balance sheet. Everyone is worried about
the high cost of cash. Meanwhile, the human genome project is
opening a Pandora's Box of opportunities. Recent clinical setbacks
have placed gene therapy under intense public scrutiny. And the
entire industry is in a state of frenetic growth coupled with
strong new science, creating a chaotic, yet incredibly exciting,
business environment.
At BDF, we
have worked with the industry leaders and startups, helping to
develop strategies, improve development processes, bring products
to market, set win-win pricing policies, and develop strategies
to strengthen market positions. We have provided insight and direction
to companies that enabled them to reap full value from their research
and development efforts. We approach our work in biotechnology
with same sense of vision, innovation and business that has made
the industry a success.
Case
study: Is it real?
|
Home | About BDF | Capabilities
| Expertise | Case
Studies |
| BDF Report | Challenge
Us | Employment | Contact
|
©
2001 Bogart Delafield Ferrier, LLC
